Literature DB >> 12960223

Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families.

D G R Evans1, M Bulman, K Young, D Gokhale, F Lalloo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12960223      PMCID： PMC1735589          DOI： 10.1136/jmg.40.9.e107

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  4 in total

1.  A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.

Authors:  D G R Evans; D M Eccles; N Rahman; K Young; M Bulman; E Amir; A Shenton; A Howell; F Lalloo
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

2.  BRCA1/2 mutation analysis in male breast cancer families from North West England.

Authors:  D G R Evans; Mike Bulman; Karen Young; Emma Howard; Stuart Bayliss; Andrew Wallace; Fiona Lalloo
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

3.  Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.

Authors:  Barbara Wappenschmidt; Alexandra A Becker; Jan Hauke; Ute Weber; Stefanie Engert; Juliane Köhler; Karin Kast; Norbert Arnold; Kerstin Rhiem; Eric Hahnen; Alfons Meindl; Rita K Schmutzler
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

4.  Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.

Authors:  A Smith; A Moran; M C Boyd; M Bulman; A Shenton; L Smith; R Iddenden; E R Woodward; F Lalloo; E R Maher; D G R Evans
Journal:  J Med Genet       Date:  2006-11-01       Impact factor: 6.318
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.